Tag: COVID-19
-
FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals
Today, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action will now make a second…
-
CDC Recommendations for People with COVID-19 and COVID-19 Close Contacts
Recommendations for People with COVID-19 Have you tested positive for COVID-19 or have mild symptoms and are waiting for test results? Here’s What To Do: Isolate. Stay at home for at least 5 days.* To keep others safe in your home, wear a mask, stay in a separate room and use a separate bathroom if…
-
Blue Origin’s 20th Mission to Space
March 21 Blue Origin today announced the sixth crew member joining New Shepard’s 20th mission will be Blue Origin’s Gary Lai, New Shepard Chief Architect. Gary joins the previously announced crew, which includes Marty Allen, husband and wife duo Sharon and Marc Hagle, Jim Kitchen, and Dr. George Nield. Gary is best known as the architect…
-
Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters
Today, the U.S. Food and Drug Administration is announcing a virtual meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Wed., April 6, to discuss considerations for future COVID-19 vaccine booster doses and the process for selecting specific strains of the SARS-CoV-2 virus for COVID-19 vaccines to address current and emerging variants.…
-
CDC Recommendation Regarding Mask Use on Public Transportation
At CDC’s recommendation, TSA will extend the security directive for mask use on public transportation and transportation hubs for one month, through April 18th. During that time, CDC will work with government agencies to help inform a revised policy framework for when, and under what circumstances, masks should be required in the public transportation corridor.…
-
NASA TV to Air NOAA’s GOES-T Launch, Prelaunch Activities
NASA will provide coverage of the prelaunch and launch activities of the National Oceanic and Atmospheric Administration’s (NOAA) next weather observing and environmental monitoring system satellite. Currently known as GOES-T, this is the third satellite in NOAA’s Geostationary Operational Environmental Satellites (GOES) – R series. GOES-T is scheduled to launch at 4:38 p.m. EST Tuesday,…
-
What You Need to Know about Omicron
Omicron in the United States CDC is working with state and local public health officials to monitor the spread of Omicron. As of December 20, 2021, Omicron had been detected in most states and territories and continues to be the dominant variant in the United States. What We Know about Omicron CDC has been collaborating with…
-
A potential at-home COVID-19 test is just as good as laboratory PCR tests, according to preclinical data
More research needed to validate test Researchers at the University of Illinois Chicago have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening. Results from an early preclinical study suggest that tests with the new assay may be just as reliable as the laboratory-based molecular tests — called PCR tests — used by hospitals…
-
NASA Commits $28 Million to Underfunded US Jurisdictions
NASA has awarded $28 million to fund the next five years of research infrastructure development across 28 jurisdictions. The Established Program to Stimulate Competitive Research (EPSCoR), a part of NASA’s Office of Stem Engagement and based out of the agency’s Kennedy Space Center in Florida, supports science and technology research and development at colleges and…
-
Are We Close to a Pill to Treat Covid? (video)
Scientist are racing to develop new tools to combat and treat COVID-19. One of those tools is an experimental pill to treat the pandemic. Merck is the first company to seek emergency us authorization from the FDA with its molnupiravir, an antiviral pill which, once approved, will become a valuable tool in the fight to…